Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer.
Lentz RW, Friedrich TJ, Blatchford PJ, Jordan KR, Pitts TM, Robinson HR, Davis SL, Kim SS, Leal AD, Lee MR, Waring MRN, Martin AC, Dominguez ATA, Bagby SM, Hartman SJ, Eckhardt SG, Messersmith WA, Lieu CH. Lentz RW, et al. Among authors: jordan kr. Clin Cancer Res. 2024 Jun 13. doi: 10.1158/1078-0432.CCR-24-0090. Online ahead of print. Clin Cancer Res. 2024. PMID: 38869830
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: jordan kr. Mol Cancer Ther. 2024 Jun 12:OF1-OF16. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38863225
Catalyzing communities of research rigour champions.
Brumback AC, Ngiam WXQ, Lapato DM, Allison DB, Daniels CL, Dougherty M, Hazlett HF, Kerr KL, Pusek S, Schrag N; NINDS workshop Catalyzing Communities of Research Rigor Champions. Brumback AC, et al. Brain Commun. 2024 Apr 9;6(3):fcae120. doi: 10.1093/braincomms/fcae120. eCollection 2024. Brain Commun. 2024. PMID: 38764774 Free PMC article.
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: jordan kr. Mol Cancer Ther. 2024 May 8. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38714351
Academic performance of students in an accelerated medical pathway.
Chen F, Jordan KA, Li W, Lam Y, Pascarella L, Coe CL. Chen F, et al. Among authors: jordan ka. Med Educ Online. 2024 Dec 31;29(1):2345444. doi: 10.1080/10872981.2024.2345444. Epub 2024 Apr 28. Med Educ Online. 2024. PMID: 38678447 Free PMC article.
1,501 results